Showing: 1 - 2 of 2 RESULTS

New Game Changers in Medicine Episode About the Discovery of the X-Ray Premieres October 14

NEW YORK, Oct. 12, 2020 /PRNewswire/ — Game Changers in Medicine, the new monthly podcast from Dramatic Health, premieres its fourth episodeX-Rays: This invisible diagnostic light was born in the dark 125 years ago” on October 14, 2020. The use of radiation in medicine and dentistry revolutionized diagnostic techniques, and its applications went beyond the healthcare field to areas like airport security.  Produced by Dramatic Health co-founder and CEO Sean T. Moloney, the series is hosted by renowned medical futurist Dr. Rubin Pillay of the University of Alabama at Birmingham (UAB).

For details on the podcast series, visit www.gamechangersinmedicine.com 

The Dramatic Health and Game Changers in Medicine teams have gathered a distinguished group of experts to discuss the science and serendipity behind the discovery of the X-ray. Dr. Daniel Margolis, professor of radiology for Weill Cornell Medical College and the head of the department’s Prostate MRI program, is joined by Kathy Joseph, a physics teacher and historian who runs the up-and-coming YouTube channel, Kathy Loves Physics and History, on the history of scientific discoveries. Dr. David Rosenthal, professor of medicine at Harvard Medical School and former medical director and president of the Leonard P. Zakim Center for Integrated Therapies at the Dana-Farber Cancer Institute, is an advisor to the series. 

Dramatic Health, a national healthcare video company, is the producer of the six-part podcast series Game Changers in Medicine. Previous episodes have included: the premiere podcast about Vitamin K and an enterprising Boston house doctor; the creation of a smallpox vaccine and its parallels to today’s urgent search for a COVID-19 vaccine; and the history of the blood thinner warfarin, a rat poison turned game-changer in cardiology.  All episodes, a series backgrounder, and additional material about the podcast series are available at  www.gamechangersinmedicine.com and can be accessed wherever you find your podcasts.

Contact: Mark G. Auerbach. [email protected]

SOURCE Dramatic Health, Inc.

Source Article

KA Imaging’s Portable Dual-energy X-ray Receives Canadian Medical Device Licence from Health Canada

Canadian market comprises more than 1,000 hospitals. Number of medical and diagnostic laboratories (which include x-ray) surpasses 3,000.

A Canadian Medical Device Licence was issued September 24 by Health Canada for Reveal 35C™, created by KA Imaging – a University of Waterloo spin-off company.

Reveal is a portable dual-energy X-ray detector that enables bone and soft-tissue differentiation without motion artifacts in a single X-ray exposure. The detector simultaneously delivers DR, bone, and tissue images in one shot. Reveal can be taken to the bedside of vulnerable patients in hospital and used easily to aid emergency procedures. It is also affordable and comes at a quarter of the price of many fixed dual-energy systems.

“Getting this Health Canada licence is a major step forward for KA Imaging, especially coupled with the recent FDA clearance. As a Canadian company we are thrilled to have received Health Canada’s approval and eagerly anticipate providing our solution to the Canadian market for advance in the field of X-ray,” said Amol Karnick, President and CEO of KA Imaging.

Statistics from the Industry Canada database from 2019 show that there are more than 1,000 hospitals (including general and specialized facilities) in the country, and more than 3,000 medical and diagnostic laboratories – including X-ray services. In addition, because the detector is portable – it is the only portable dual-energy solution on the market – less obvious sectors can also benefit from the technology.

“At long-term care facilities, which care for vulnerable populations that can suffer from mobility limitations or health concerns, taking the detector to the patient can be very beneficial,” said Dr. Karim S. Karim, CTO of KA Imaging.

Reveal is already being used in clinical trials with promising results. The detector is being tested on patients suspected of having lung cancer at Grand River Hospital in Kitchener, and for detection of pneumonia (including COVID-19) in a Toronto-based hospital.

“Early triaging is an essential countermeasure to prevent the spread of COVID-19 infection, and we are confident that our technology can make a significant contribution,” said Karim.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200930005044/en/

Contacts

Fernanda Fraga
ffraga@kaimaging.com
226 215 9897

Source Article